Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CLOFIBRATE CRS (0.5 ML)

CLOFIBRATE CRS (0.5 ML)

637-07-0

DISCOVER
Clomifene citrate CRS, 50mg

Clomifene citrate CRS, 50mg

50-41-9

DISCOVER
Clomifene citrate for performance test CRS, 50mg

Clomifene citrate for performance test CRS, 50mg

50-41-9

DISCOVER
Cefazolin sodium salt

Cefazolin sodium salt

27164-46-1

DISCOVER
CLOMIPRAMINE HYDROCHLORIDE CRS (50 MG)

CLOMIPRAMINE HYDROCHLORIDE CRS (50 MG)

17321-77-6

DISCOVER
CLONAZEPAM CRS - * PSY (50 MG)

CLONAZEPAM CRS - * PSY (50 MG)

1622-61-3

DISCOVER
CLONAZEPAM IMPURITY B CRS (5 MG)

CLONAZEPAM IMPURITY B CRS (5 MG)

NA

DISCOVER
CLONIDINE HYDROCHLORIDE CRS (25 MG)

CLONIDINE HYDROCHLORIDE CRS (25 MG)

4205-91-8

DISCOVER
CLOSTRIDIA (MULTI-COMPONENT) RABBIT ANTISERUM(FOR VACCINES-V

CLOSTRIDIA (MULTI-COMPONENT) RABBIT ANTISERUM(FOR VACCINES-V

NA

DISCOVER
CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - VET.

CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - VET.

NA

DISCOVER
CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - HUMA

CLOSTRIDIUM TETANI GUINEA PIGANTISERUM (FOR VACCINES - HUMA

NA

DISCOVER
CLOSTRIDIUM TETANI RABBIT ANTISERUM (FOR VACCINES - VET. USE

CLOSTRIDIUM TETANI RABBIT ANTISERUM (FOR VACCINES - VET. USE

NA

DISCOVER